However, the clinical presentation and courses of previously reported patients with WIP deficiency were more heterogeneous than those of WAS patients (6–8), especially with regards to very early onset of severe, life-threatening immunodeficiency. This evidence concerns the gene WIPF1 and immunodeficiency disease.